Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Turkish Journal of Urology|March 9, 2017
Cyanoacrylic tissue glues: Biochemical properties and their usage in urologySema Nur Ayyıldız, Ali AyyıldızTurkish Journal of Urology|September 2, 2015
PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancerSema Nur Ayyıldız, Ali AyyıldızTurkish Journal of Urology|February 28, 2018
3D printing in urology: Is it really promising?Berat Cem Özgür, Ali AyyıldızTurkish Journal of Urology|November 22, 2018
Do AB0 blood groups affect lower urinary tract symptoms?Erdal Benli, Abdullah Çırakoğlu, Ercan Öğreden, et al.Turkish Journal of Medical Sciences|January 13, 2017
Is there a difference between Parkinson disease patients and a control group in terms of urinary symptoms and quality of life?Erdal Benli, Fahriye Feriha Özer, Yasemin Kaya, et al.The Kaohsiung Journal of Medical Sciences|February 19, 2011
Phosphodiesterase 5 inhibitors attenuate renal tubular apoptosis after partial unilateral ureteral obstruction: an experimental studyTurgay Akgül, Emre Huri, Hatice Yagmurdur, et al.Urology Annals|August 1, 2015
Effect of obesity on International Prostate Symptom Score and prostate volumeKazım Yelsel, Ergün Alma, Alper Eken, et al.Neurourology and Urodynamics|July 14, 2021
Association between the Trp64Arg polymorphism of the ADRB3 gene and overactive bladderAbdullah Çırakoğlu, Arta Fejzullahu, Erdal Benli, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|May 19, 2016
The association between symptoms of sexual dysfunction and age at onset in Parkinson's diseaseTuba Özcan, Erdal Benli, Feriha Özer, et al.Revista Da Associacao Medica Brasileira (1992)|April 18, 2019
Positive outcomes of phosphodiesterase type 5 inhibitor on histopathologic and biochemical changes induced by ureteral obstructionSibel Köktürk, Erdal Benli, Ali Ayyıldız, et al.Pageof 2